Drugs Made In America Acquisition Corp. SEC filings DMAAU
Drugs Made In America Acquisition Corp. has 80 filings in SEC EDGAR's recent list, going back to Aug 1, 2024. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 21, 2026 (material agreement, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 425 | Current report | Oct 21, 2026 | — |
| 8-K |
Current report
Material agreement, Other events
|
Oct 21, 2026 | Oct 13, 2026 |
| 425 | Current report | Sep 14, 2026 | — |
| 8-K |
Current report
Material agreement
|
Sep 14, 2026 | Sep 8, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 425 | Current report | Jul 20, 2026 | — |
| 8-K |
Current report
Material agreement
|
Jul 20, 2026 | Jul 14, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 425 | Current report | May 5, 2026 | — |
| 8-K |
Current report
Material agreement
|
May 5, 2026 | Apr 29, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results, Other events
|
May 1, 2026 | Apr 27, 2026 |
| 8-K |
Current report
Material agreement
|
Apr 28, 2026 | Apr 22, 2026 |
| DEFR14A | Revised definitive proxy statement | Apr 16, 2026 | — |
| 10-K | Annual report | Apr 15, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Apr 14, 2026 | Apr 27, 2026 |
| 8-K |
Current report
Other events
|
Apr 8, 2026 | Apr 7, 2026 |
| NT 10-K | Notification of late filing | Apr 1, 2026 | Dec 31, 2025 |
| PRE 14A | Preliminary proxy statement | Mar 27, 2026 | Mar 27, 2026 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Mar 27, 2026 | Mar 23, 2026 |
| 8-K |
Current report
Other events
|
Mar 6, 2026 | Mar 6, 2026 |
| 8-K |
Current report
Officer or director change
|
Mar 6, 2026 | Feb 28, 2026 |
| 10-Q | Quarterly report | Nov 18, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Officer or director change
|
Nov 18, 2025 | Oct 8, 2025 |
| NT 10-Q | Notification of late filing | Nov 17, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | May 20, 2025 | Mar 31, 2025 |
| NT 10-Q | Notification of late filing | May 15, 2025 | Mar 31, 2025 |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Unregistered share sale, Other events
|
Feb 25, 2025 | Feb 18, 2025 |
| 8-K |
Current report
Other events
|
Feb 24, 2025 | Feb 20, 2025 |
| 8-K |
Current report
Other events
|
Feb 4, 2025 | Jan 29, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
|
Jan 30, 2025 | Jan 27, 2025 |
| 424B4 | Prospectus | Jan 29, 2025 | — |
| EFFECT | Filing | Jan 27, 2025 | — |
| CORRESP | Letter to the SEC | Jan 23, 2025 | — |
| CORRESP | Letter to the SEC | Jan 23, 2025 | — |
| POS AM | Registration statement | Jan 22, 2025 | — |
| POS AM | Post-effective amendment | Jan 14, 2025 | — |
| CERT | Filing | Jan 8, 2025 | — |
| EFFECT | Filing | Jan 7, 2025 | — |
| 8-A12B | For registration of certain classes | Jan 7, 2025 | — |
| S-1/A | Amended registration statement | Jan 6, 2025 | — |
| CORRESP | Letter to the SEC | Jan 3, 2025 | — |
| CORRESP | Letter to the SEC | Jan 3, 2025 | — |
| S-1/A | Amended registration statement | Dec 9, 2024 | — |
| S-1/A | Amended registration statement | Nov 25, 2024 | — |
| S-1/A | Amended registration statement | Nov 7, 2024 | — |
| S-1/A | Amended registration statement | Sep 27, 2024 | — |
| CORRESP | Letter to the SEC | Sep 6, 2024 | — |
| S-1/A | Amended registration statement | Sep 6, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 27, 2024 | — |
| S-1 | Registration statement | Aug 1, 2024 | — |
Showing 52 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Blank Checks (SIC 6770)
- Listed as
- DMAA (Nasdaq), DMAAR (Nasdaq), DMAAU (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- New York, NY
- SEC filer status
- , Emerging growth company
- SEC CIK
- 2028614
Other Blank Checks companies
- Drugs Made In America Acquisition II Corp. DMII
- EQV Ventures Acquisition Corp. II EVAC
- Bain Capital GSS Investment Corp. BCSS
- Cantor Equity Partners IV, Inc. CEPF
- Churchill Capital Corp XII CXII
- American Exceptionalism Acquisition Corp. A AEXA
- New America Acquisition I Corp. NWAX
- Ares Acquisition Corp III AAC
Source: SEC EDGAR filings. This is company-reported data, not investment advice.